Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4493
+0.0161 (3.72%)
At close: Aug 20, 2026, 4:00 PM EDT
0.4493
0.00 (0.00%)
After-hours: Aug 20, 2026, 4:10 PM EDT
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $48.44 million as of August 20, 2026. Its market cap has increased by 597.23% in one year.
Market Cap
48.44M
Enterprise Value
48.43M
1-Year Change
597.23%
Ranking
Category
Stock Price
$0.45
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $48.44M, an increase of 40.45%. That is a compound annual growth rate of 19.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 48.44M | -8.31% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 54.61M |
| Immutep | 54.49M |
| TScan Therapeutics | 53.88M |
| aTyr Pharma | 51.02M |
| Instil Bio | 49.92M |
| Mereo BioPharma Group | 49.42M |
| Context Therapeutics | 47.78M |
| Metagenomi Therapeutics | 46.65M |